BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 17 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 18 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 19 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 day ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 day ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 17 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 18 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 19 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 day ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 1 day ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago
ADVERTISEMENT
Market News

Celestica Shares Slip Despite Strong Q4 2025 Results; Stock Near 52-Week High

Celestica Inc. (NYSE: CLS) shares were trading lower in midday U.S. session after the company reported robust fourth-quarter and full-year 2025 results, though broader profit-taking weighed on the stock. CLS recently traded below its recent peaks, with a 52-week range of roughly $58 to about $363 on the NYSE, reflecting heavy volatility and strong underlying […]

January 29, 2026 2 min read

Celestica Inc. (NYSE: CLS) shares were trading lower in midday U.S. session after the company reported robust fourth-quarter and full-year 2025 results, though broader profit-taking weighed on the stock. CLS recently traded below its recent peaks, with a 52-week range of roughly $58 to about $363 on the NYSE, reflecting heavy volatility and strong underlying gains through 2025.

Quarterly Results

Celestica reported Q4 2025 revenue of $3.655 billion, up approximately 44% year-over-year and above guidance of $3.325 billion–$3.575 billion. Adjusted non-GAAP operating margin was 7.7%, slightly above expectations, and adjusted EPS was $1.89, up about 70% from Q4 2024 and above the guided range.

On a GAAP basis, earnings per share were $2.31 with a margin of 8.6% of revenue. CCS segment revenue jumped about 64%, while the Advanced Technology Solutions segment declined slightly versus the prior year.

Full-Year 2025

For the full year, Celestica posted revenue of about $12.4 billion, a 28% increase from 2024, and adjusted non-GAAP EPS of $6.05, up roughly 56% year-over-year. Free cash flow was $458.3 million, and GAAP operating margin was 8.4%.

Guidance and Outlook

Management provided 2026 guidance with an elevated outlook, forecasting revenue growth to about $17.0 billion and adjusted EPS of $8.75, alongside increased capital expenditures to support capacity expansion, particularly in AI and hyperscale compute infrastructure.

ADVERTISEMENT

Market Reaction and Analyst Activity

There were no widely reported analyst upgrades or formal price-target changes linked directly to today’s release at the time of publication. The stock has shown strong performance in 2025, trading near the upper end of its 52-week range, yet saw some pullback after the release, consistent with broader profit-taking in tech and high-growth hardware/software equities.

Sector and Macro Context

Celestica’s results come amid choppy trading in technology and AI-linked names, where macroeconomic pressures, rising interest rates and rotation out of high-momentum stocks have impacted valuations. Investors have been weighing strong fundamentals in data-center demand against sector-wide headwinds.

ADVERTISEMENT